Search

Author/Creator Harris, Kristina M

1. A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes. Issue 1 (13th November 2021)

Authors:
Marwaha, Ashish K; Chow, Samuel; Pesenacker, Anne M; Cook, Laura; Sun, Annika; Long, S Alice; Yang, Jennie H M; Ward-Hartstonge, Kirsten A; Williams, Evangelia; Domingo-Vila, Clara; Halani, Khalif; Harris, Kristina M; Tree, Timothy I M; Levings, Megan K; Elliott, Thomas; Tan, Rusung; Dutz, Jan P
Journal:
Immunotherapy advances
Issue:
Volume 2:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Alpha‐1 antitrypsin treatment of new‐onset type 1 diabetes: An open‐label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics. Issue 5 (7th May 2018)

Authors:
Weir, Gordon C; Ehlers, Mario R; Harris, Kristina M; Kanaparthi, Sai; Long, Alice; Phippard, Deborah; Weiner, Lia J; Jepson, Brett; McNamara, James G; Koulmanda, Maria; Strom, Terry B
Journal:
Pediatric diabetes
Issue:
Volume 19:Issue 5(2018)
Page Start:
945
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search